mardi 18 octobre 2016

Onco Actu du 18 octobre 2016

2.7 Etiologie - Obésité

One More Reason to Stay Trim: Reduce Your Liver Cancer Risk [AACR]

4. Dépistage, diagnostic et pronostic

LLNL scientists develop a new method to measure radiation dose in cancer patients [LLNL]

4.2 Dép., diag. & prono. - Génome

Veritas Genetics Lands $30M for $1,000 Genome Sequencing [Xconomy]

5.4 Traitements - Economie

‘Fast track’ cost effective treatments for patients following NICE changes [European Pharmaceutical Review]

Drug maker fined for shorting supplies of cancer drugs in order to raise prices [STAT]

HHS is urged to allow a drug maker to export cheap versions of pricey cancer med [STAT]

6. Lutte contre les cancers

A new era for pancreatic cancer: The Dream Team [Cancer Research UK]

6.10 Politiques

Cancer targets may delay diagnosis of other conditions, say doctors leaders [BMA]

6.10.1 Politiques (USA)

Cancer Moonshot Task Force and Vice President Detail Necessary Next Steps to Accelerate Cancer Research and Prevention [ACS]

Here are 3 big projects the White House cancer moonshot is pursuing [STAT]

FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance Cancer Moonshot Goals [White House]

White House To Announce Big Push For Cancer Blood Tests [Forbes]

Biden’s moonshot cancer plan calls for more data sharing [Science]

Cancer Moonshot program is 'close to gigantic progress', Joe Biden says [The Guardian]

Report of the Cancer Moonshot Task Force: Executive Summary [Medium]

The Best—and Worst—Things About Joe Biden’s Cancer Moonshot [MIT Technology Review]

VP Biden to report on Cancer Moonshot progress [Reuters]

6.11 Patients

A cancer patient and pathologist — brought together by Twitter — strike up an unlikely connection [STAT]

Insecurity, guilt and stigma: The reality of going back to work after breast cancer [The Telegraph]

6.5 Médecines alternatives

Dr. Richard Rawlins Reveals the Real Secrets of Alternative Medicine [Science-Based Medicine]

6.6 Publications

Richard Lehman’s journal review—17 October 2016 [BMJ]

6.7 DMP, Big Data & applis

IBM Is Counting on Its Bet on Watson, and Paying Big Money for It [NY Times]

Thousands More Patients Will Soon Be Able to Use IBM's Watson to Fight Cancer [Fortune]